Federal Register Notice: FDA is rescheduling a 2/13 public workshop convened by the Institute of Medicine entitled “Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks in Drug Regulatory Decision-Making,” to 5/12. To view this notice, click here.
